Search results
Results From The WOW.Com Content Network
Form 8-K. Form 8-K is a very broad form used to notify investors in United States public companies of specified events that may be important to shareholders or the United States Securities and Exchange Commission. This is one of the most common types of forms filed with the SEC. After a significant event like bankruptcy or departure of a CEO, a ...
The Pfizer–BioNTech COVID-19 vaccine, sold under the brand name Comirnaty, [ 2][ 32] is an mRNA-based COVID-19 vaccine developed by the German biotechnology company BioNTech. For its development, BioNTech collaborated with the American company Pfizer to carry out clinical trials, logistics, and manufacturing. [ 44][ 45] It is authorized for ...
Omicron (B.1.1.529) is a variant of SARS-CoV-2 first reported to the World Health Organization (WHO) by the Network for Genomics Surveillance in South Africa on 24 November 2021. [ 10][ 11] It was first detected in Botswana and has spread to become the predominant variant in circulation around the world. [ 12]
Zoetis. Zoetis Inc. (/zō-EH-tis/ [ 4]) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. [ 5][ 4][ 6] The company was a subsidiary of Pfizer, [ 7] the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company.
Japan has so far approved Pfizer–BioNTech, Moderna and Oxford–AstraZeneca for use. In April 2024, data from the government shows that 79.5% of people have had their second dose, while 80.4% have received first shot. [ 7] Today, 79 percent of Japanese people have received two doses of a COVID-19 vaccine; 67 percent have received a third ...
Biontech FY 2023 report [ 1] BioNTech SE ( / biːˈɒntɛk / bee-ON-tek; or / baɪˈɒntɛk / bye-ON-tek[ 2] short for Biopharmaceutical New Technologies) is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.
The COVID-19 vaccination campaign in the United States is an ongoing mass immunization campaign for the COVID-19 pandemic in the United States. The Food and Drug Administration (FDA) first granted emergency use authorization to the Pfizer–BioNTech vaccine on December 10, 2020, [ 7] and mass vaccinations began four days later. The Moderna ...
On 21 December 2020, the CHMP recommended granting a conditional marketing authorization for the Pfizer-BioNTech COVID‑19 vaccine, Comirnaty (active ingredient tozinameran), developed by BioNTech and Pfizer. [144] [145] [22] The recommendation was accepted by the European Commission the same day. [144] [146] [147] [148]